Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig

Nature Medicine

Volumn 4, Issue 2, 1998, Pages 194-200

  Olthoff, Kim M ^a   Judge, Thomas A ^a   Gelman, Andrew E ^a   Da Shen, Xiu ^a   Hancock, Wayne W ^a   Turka, Laurence A ^b   Shaked, Abraham ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 901 BRB 1 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; RECOMBINANT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TARGETING; GENE TRANSFER; GRAFT PRESERVATION; GRAFT SURVIVAL; HELPER CELL; IMMUNE RESPONSE; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ASPARTATE AMINOTRANSFERASES; CRYOPRESERVATION; GENE TRANSFER TECHNIQUES; GRAFT SURVIVAL; IMMUNOCONJUGATES; LIVER; LIVER TRANSPLANTATION; PERFUSION; RATS; RATS, INBRED ACI; RATS, INBRED BN; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031906191     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0298-194     Document Type: Article

References (25)

1. Grusby, M.J., et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. USA 90, 3913-3917 (1993).
2. Auchincloss, J., Jr., et al. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90, 3373-3377 (1993).
3. Cozzi, D. & White, D.J. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1, 964-966 (1995).
4. Byrne, G.W, et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63, 149-155 (1997).
5. Shaked, A., et al. Adenovirus-mediated gene transfer in the transplant setting II: Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation 57, 1508-1511 (1994).
6. Drazan, K.E., et al. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116, 197-204 (1994).
7. Drazan, K.E., Chen, X.D., Busuttil, R.W., Csete, M. & Shaked, A. Gene transfer in the transplant setting III: Variables affecting recombinant gene expression in liver grafts. Transplantation 59, 670-673 (1995).
8. Drazan, K.E., et al. Hepatic liver function is preserved after adenoviral-mediated gene transfer. J. Surg. Res. 59, 299-304 (1995).
9. Lin, H., et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allograft induced by CTLA4lg plus donor-specific transfusion. J. Exp. Med. 178, 1801-1806 (1993).
10. Baliga, P., et al. CTLA4lg prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 58, 1082-1090 (1994).
11. Lenschow, D.J., et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257, 789-792 (1992).
12. Wang, J., Jiano S., Wolff J.A., & Knechtle S.J. Gene transfer and expression in rat cardiac transplant. Transplantation 53, 703-705 (1992).
13. 3. Shaked, A., et al. Retroviral-mediated gene transfer into rat experimental liver transplant. Transplantation 57, 32-32 (1994).
14. Csete, M.E., et al. Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred gene in cold preserved hepatocytes. Transplantation 57, 1502-1507 (1994).
15. Tripathy, S.K., Black, N.B., Goldwasser, E., & Leiden, J.M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550 (1996).
16. Yang, Y., Su, Q. & Wilson, J.M. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70, 7209-7212 (1996).
17. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C. & Wilson, J.M. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144 (1996).
18. Linsley, P.S., et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795 (1992).
19. Sayegh, M.H., et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181, 1869-1874 (1995).
20. Judge, T.A., et al. The in vivo mechanisms of action of CTLA4lg. J. Immunol. 156, 2294-2299 (1996).
21. Kamada, N. & Calne, R.Y. Orthotopic liver transplantation in the rat: Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28, 47 (1979).
22. Lin, H., lammattoni, M.D., Modblum, J.R. & Boiling, S.F. Experimental heterotopic heart transplantation without ischemia or reperfusion. J. Heart Transplant. 9, 720 (1990).
23. Hirt, J.M.B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369 (1967).
24. Graham, F.L. & van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 2(2), 456-467 (1973).
25. Hancock, W.W., et al. Costimulatory function and expression of CD40-ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 93, 13967-13972 (1996).